Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Journal of Community Genetics|November 30, 2021
Evaluating the model of offering expanded genetic carrier screening to high school students within the Sydney Jewish communityKristine Barlow-Stewart, Kayley Bardsley, Elle Elan, et al.The Journal of Dermatology|June 26, 2024
The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1Brieana Dance, Alice Dardare, Jane Fleming, et al.Familial Cancer|June 19, 2023
Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1Mathilda Wilding, Jane Fleming, Katrina Moore, et al.Women'S Health (London, England)|June 29, 2025
The development and evaluation of educational resources for young women with neurofibromatosis type 1 undergoing breast cancer surveillanceCaitlin Forwood, Emma Hartley, Jane Fleming, et al.Journal of Genetic Counseling|November 26, 2024
Reproductive decision-making experiences of Australian adults with neurofibromatosis type 1 and schwannomatosisTina Gonzalez, Alison McLean, Jane Fleming, et al.Journal of Paediatrics and Child Health|August 24, 2021
Paediatric genomic testing: Navigating genomic reports for the general paediatricianMargit Shah, Arthavan Selvanathan, Gareth Baynam, et al.Journal of Paediatrics and Child Health|June 14, 2014
Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experienceRaelia M Lew, Leslie Burnett, Anné L Proos, et al.Journal of the American College of Cardiology|July 21, 2018
Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic CardiomyopathyRichard D Bagnall, Jodie Ingles, Marcel E Dinger, et al.The Journal of Investigative Dermatology|June 18, 2023
Current and Emerging Imaging Techniques for Neurofibromatosis Type 1-Associated Cutaneous NeurofibromasYingjoy Li, Jaishri O Blakeley, Ina Ly, et al.American Heart Journal|June 26, 2023
Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trialMichael P Gray, Yemima Berman, Giordano Bottà, et al.Pageof 3